Impact of Metabolic-Associated Fatty Liver Disease on the Severity and Structural Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

Diabetic retinopathy represents a devastating microvascular complication traditionally conceptualized strictly as the consequence of localized retinal capillary ischemia and chronic hyperglycemic toxicity. The modern diagnostic paradigm recognizing metabolic-associated fatty liver disease (MAFLD) as a highly active systemic pathology requires a radical reevaluation of how ectopic hepatic steatosis influences distant neurovascular networks. This prospective observational investigation aimed to quantify the exact clinical and morphofunctional impact of MAFLD on the progression velocity of diabetic retinopathy. An analytical cohort comprising 315 adult patients with established Type 2 Diabetes Mellitus was stratified based on the presence or absence of concomitant MAFLD and monitored continuously over a 36-month longitudinal trajectory. Utilizing high-resolution spectral-domain optical coherence tomography and ultra-widefield fundus photography, the structural degradation of the blood-retinal barrier was meticulously mapped. The resultant data exposed a profoundly accelerated ophthalmic deterioration in the dual-pathology cohort. Patients harboring MAFLD demonstrated a 2.8-fold higher incidence of progression to vision-threatening proliferative diabetic retinopathy compared to their isolated diabetes counterparts. Central subfield macular thickness, the definitive marker of diabetic macular edema, expanded aggressively in the MAFLD arm, increasing by an average of 48.4 ± 12.1 μm annually, sharply contrasting the 14.2 ± 5.6 μm annual expansion observed in the non-steatotic group. Advanced hepatic fibrogenesis, quantitatively assessed via the non-invasive FIB-4 index, exhibited a dominant independent correlation with retinal neuroglial degradation and capillary non-perfusion areas (r = 0.69, p < 0.001). The steatotic liver operates as a powerful endocrine disruptor, continuously secreting pro-angiogenic and pro-inflammatory hepatokines that fundamentally compromise retinal pericyte survival. Integrating transient elastography and comprehensive hepatic profiling into routine ophthalmological screening algorithms provides a critical prognostic advantage, facilitating the early deployment of targeted systemic interventions before irreversible retinal architectural collapse occurs.